Insider Transactions in Q4 2022 at Artivion, Inc. (AORT)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 14
2022
|
Amy Horton VP, Chief Accounting Officer |
SELL
Bona fide gift
|
Direct |
2,000
-1.96%
|
$26,000
$13.21 P/Share
|
Dec 14
2022
|
Amy Horton VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,226
-3.07%
|
$41,938
$13.57 P/Share
|
Nov 08
2022
|
Franz Peter Barthold VP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
12,511
+27.79%
|
-
|
Nov 08
2022
|
Amy Horton VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,831
+10.11%
|
-
|
Nov 08
2022
|
Marshall S. Stanton SVP, Clinical & MD Affair |
BUY
Grant, award, or other acquisition
|
Direct |
19,447
+33.16%
|
-
|
Nov 08
2022
|
Rochelle L. Maney VP, Quality |
BUY
Grant, award, or other acquisition
|
Direct |
11,831
+33.07%
|
-
|
Nov 08
2022
|
Elizabeth A Hoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,066
+50.0%
|
-
|
Nov 08
2022
|
James P Mackin President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
116,954
+19.06%
|
-
|
Nov 08
2022
|
Jean F Holloway SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
22,439
+15.36%
|
-
|
Nov 08
2022
|
David Ashley Lee Executive VP, COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
36,718
+10.0%
|
-
|
Nov 08
2022
|
John E Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,303
+16.85%
|
-
|
Nov 08
2022
|
Matthew A Getz VP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
13,191
+29.25%
|
-
|
Nov 08
2022
|
Andrew M Green VP Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
12,511
+39.92%
|
-
|
Nov 08
2022
|
Dennis B Maier SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
19,447
+31.52%
|
-
|
Nov 04
2022
|
Rochelle L. Maney VP, Quality |
SELL
Payment of exercise price or tax liability
|
Direct |
214
-1.74%
|
$2,354
$11.18 P/Share
|